If you’re interested in a pre-IPO investment opportunity for an innovative, non-invasive test for diabetes, please let me know, and I’ll send you the Investment Overview. The new platform will also be the basis of other tests, such as cancer markers, hormones, and allergens.
According to Peter Nichol on LinkedIn, “Remember 62% of all personal bankruptcies in the United States are due to healthcare bills and 72% of these people HAD healthcare insurance before bankruptcy.” He was referring to the ever-narrowing margins available to Hospitals to fund new technology, like Medical Imaging Equipment. The gist of it was a question about the wisdom of GE to make Medical Technology one of the three pillars of its new restructure. I wonder if he knows how much GE makes on Medical Imaging Equipment sales in the U.S. It’s huge – about double what it makes elsewhere in the world. That is, unless things have drastically changed since I left in ’06. I doubt it.